Related Experiment Video
Updated: Jul 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Cholesterol lowering to prevent stroke: who, when, and how?
1Feinberg School of Medicine of Northwestern University, 710 North Lake Shore Drive, Abbott Hall, 11th Floor, Chicago, IL 60611, USA. r-bernstein@northwestern.edu.
Statin therapy significantly reduces ischemic stroke risk in high-risk patients. Early and consistent treatment, especially with high-dose statins, lowers recurrent stroke and coronary event risks, highlighting the need for improved physician adherence to guidelines.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- The relationship between low-density-lipoprotein (LDL) cholesterol and ischemic stroke risk is debated.
- Recent clinical trials demonstrate the efficacy of statin therapy in mitigating stroke risk.
Purpose of the Study:
- To evaluate the impact of LDL reduction through statin agents on ischemic stroke risk.
- To assess the benefits of statin therapy in patients with cerebrovascular disease and those who have experienced a transient ischemic attack or stroke.
Main Methods:
- Analysis of recent clinical trial data on statin use in high-risk populations.
- Review of outcomes in patients with and without prior cerebrovascular disease treated with statins.
- Focus on high-dose statin therapy in patients with recent transient ischemic attack or ischemic stroke.
Main Results:
- Statin therapy reduces the risk of first ischemic stroke within 1-2 years in high-risk individuals.
- Patients with cerebrovascular disease on statins show reduced risk of coronary and major vascular ischemic events.
- High-dose statins significantly decrease risks of recurrent stroke and coronary events in patients with recent TIA or stroke.
Conclusions:
- Most patients with ischemic cerebrovascular disease should be prescribed statin drugs.
- Current treatment levels with statins for stroke patients fall short of recommendations, indicating a need for improved clinical practice.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis IV: Nursing Management